Trépo C, Merle P, Zoulim F. Hépatites virales B et C. Collection Pathologie, sciences, formation. Paris: Edition Jonh Libbey Eurotext, 2006: 1-246
OMS. Hépatite C: Prévalence mondiale. Relevé épidémiologique hebdomadaire N° 49, 10 décembre 1999, OMS. WHO information Aide-mémoire N° 164 Révisé Octobre 2000. Available from : URL : http//www.who.int
Delwaide J, Bourgeois N, Colle I, Robaeys G. Risk factors for hepatitis C: past, present and future. Acta Gastroenterol Belg 2002; 65: 87-89
Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, Butler K. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000; 356: 904-907
Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30: 1054-1058
Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2: 293-302
Diarra A, Kouriba B, Baby M, Murphy E, Lefrere JJ. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol 2009; 16: 444-447
AIDS epidemic update (December 2007). UNAIDS/WHO, 2007: 1-55. Available from: URL: http://www.un-ngls.org/ spip.php?page=article_s&id_article=383ref
Report on the global AIDS epidemic, August 2008. Available from: URL: http: //www.unaids.org/en/dataanalysis/ knowyourepidemic/epidemiologypublications/ 2008reportontheglobalaidsepidemic
Santiago ML, Range F, Keele BF, Li Y, Bailes E, Bibollet- Ruche F, Fruteau C, Noë R, Peeters M, Brookfield JF, Shaw GM, Sharp PM, Hahn BH. Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2. J Virol 2005; 79: 12515-12527
Enquête Démographique et de Santé du Mali. 2006. Available from: URL: http//www.measuredhs.com/pubs/pdf/ FR199/FR199.pdf
Piche J, Morgand J, Revol F, Lacoux X, Rincon M, Leportier M. CDB0075-Development of a new HIV immunochromatographic assay for the rapid detection of Human Immunodeficiency Virus antibodies. Proceedings of XVI International AIDS Conference; 2006 Aug 13-18; Toronto, Canada
Plantier JC, Maniez M, Barin F, Kreplak G, Diagbouga PS, Cortes-Martins H, Menan H, Piche J. Evaluation of a new rapid test: VIKIA® HIV 1/2. Poster Presentation AIDS 2008: THPE 0053
Farvacque-Vitkovic C, Casalis A, Mah D, Eghoff C. Developpement of the cities of Mali. Challenges and Priorities. World Bank Africa Region Working Paper, number serie 104/a, 2007: 1-1. Available from: URL: http//www.worldbank. org/afr/wps/wp104_english.pdf
Annuaire Système Local d'Information Sanitaire du Mali, 2007: 1-117. Available from : URL : http://www.sante.gov. ml/docs/pdf/slis2007.pdf
Faulques B, Michault A, Sevidjian B, Barau G, Pawlotsky JM, Dhumeaux D. Prevalence of hepatitis C virus infection in pregnant woman on the island of Réunion. Gastroenterol Clin Biol 1999; 23: 355-358
Ndong-Atome GR, Makuwa M, Njouom R, Branger M, Brun-Vézinet F, Mahé A, Rousset D, Kazanji M. Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa. BMC Infect Dis 2008; 8: 82
Ilboudo D, Sawadogo A, Simpore J. Hepatitis C and HIV co-infection in pregnant women, Ouagadougou (Burkina Faso). Editions scientifiques et médicales Elsevier SAS Médecine et maladies infectieuses 2003; 33: 276-279
Abid S, Fkih S, Khlass B, Cherif W, Toumi NH, Jenhani F, Boukef K. Screening and confirmation of anti-HCV antibodies in Tunisian blood donors. Transfus Clin Biol 1997; 4: 221-226
Serme AK, Ilboudo PD, Samandoulgou A, Simpore J, Bougouma A, Sombie AR. Portage du virus de l'hépatite C chez les femmes enceintes et transmission mère-enfant à Ouagadougou, Burkina Faso. Santé publique: courte note n°2764, juin 2005. Bull Soc Pathol Exot 2006; 99: 108-109
Jeannel D, Fretz C, Traore Y, Kohdjo N, Bigot A, Pê Gamy E, Jourdan G, Kourouma K, Maertens G, Fumoux F, Fournel JJ, Stuyver L. Evidence for high genetic diversity and longterm endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 1998; 55: 92-97
Ruggieri A, Argentini C, Kouruma F, Chionne P, D'Ugo E, Spada E, Dettori S, Sabbatani S, Rapicetta M. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 1996; 77 (Pt 9): 2073-2076
Nicot T, Rogez S, Denis F. Epidémiologie de l'hépatite C en Afrique. Gastroenterol Clin Biol 1997; 21: 596-606
Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 2006; 11: 951-954
Seremba E, Ocama P, Opio CK, Kagimu M, Thomas DL, Yuan HJ, Attar N, Lee WM. Poor performance of hepatitis C antibody tests in hospital patients in Uganda. J Med Virol 2010; 82: 1371-1378
Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M. Prévalence de l'infection par le virus de l'hépatite-C au Maroc et évaluation des tests sérologiques de dépistage pour la prédiction de la virémie. Pathologie Biologie 2009; 57: 368-372
O'Reilly JI, Ocama P, Opio CK, Alfred A, Paintsil E, Seremba E, Sofair AN. Risk Factors and Seroprevalence of Hepatitis C among Patients Hospitalized at Mulago Hospital, Uganda. J Trop Med 2011; 2011: 598341
Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study. J Med Virol 2004; 74: 34-40
Chevaliez S, Pawlotsky JM. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006; 3: 35-40
Chevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 2007; 13: 2461-2466
Pawlotsky JM, Lonjon I, Hezode C, Raynard B, Darthuy F, Remire J, Soussy CJ, Dhumeaux D. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories. Hepatology 1998; 27: 1700-1702
Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002; 36: S65-S73
Vermeersch P, Van Ranst M, Lagrou K. Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory. J Clin Virol 2008; 42: 394-398
Pirillo MF, Bassani L, Germinario EA, Mancini MG, Vyankandondera J, Okong P, Vella S, Giuliano M. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol 2007; 79: 1797-1801
Ndjomou J, Kupfer B, Kochan B, Zekeng L, Kaptue L, Matz B. Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J Med Virol 2002; 66: 179-186
Cao J, Chen Q, Zhang H, Qi P, Liu C, Yang X, Wang N, Qian B, Wang J, Jiang S, Yang H, Sun S, Pan W. Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus. PLoS One 2011; 6: e18477
Masson S, Volle P, Bonneau J. Virus de l'hépatite C: relations entre la sérologie, le taux d'ALAT et la présence d' ARN circulant. Transfusion Clinique et Biologique 1998; 5 (Suppl 1): S87-S88
Aceti A, Taliani G, de Bac C, Sebastiani A. Anti-HCV false positivity in malaria. Lancet 1990; 336: 1442-1443
Sonmez E, Ozerol IH, Senol M, Kizilkaya N, Sahin K, Ozbilge H. False-positive reaction between syphilis and hepatitis C infection. Isr J Med Sci 1997; 33: 724-727
Seo YS, Jung ES, Kim JH, Jung YK, Kim JH, An H, Yim HJ, Yeon JE, Byun KS, Kim CD, Ryu HS, Um SH. Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia. Korean J Intern Med 2009; 24: 302-308
Konaté A. Epidémiologie de l'infection par le virus de l' hépatite B en Afrique. DEVELOPPEMENT et SANTE; Information permanente des acteurs de santé, 2012: 1. Available from: URL: http://devsante.org/.../epidemiologie-delinfection- par-le-virus-de-lhepatite